Impact of Hospitalist-Led Care on Glycemic Control Among Hospitalized Adults with Diabetes in Korea

<b>Background/Objectives</b>: Hyperglycemia in hospitalized patients is associated with an increased risk of complications, morbidity, mortality, and healthcare costs, regardless of a prior diagnosis of diabetes. The hospitalist system can improve various outcomes, including length of stay, medical costs, patient satisfaction, and mortality rates. However, the effects of hospitalist care on blood glucose control in hospitalized patients remain unclear. This study aimed to assess the specific effects of hospitalist services on blood glucose control in hospitalized patients, with a focus on hyperglycemia management and patient outcomes. <b>Methods:</b> This retrospective study reviewed the electronic medical records of patients diagnosed with diabetes at Yonsei Severance Hospital in Yongin, between March 2020 and February 2022. It included adults aged ≥20 years who were hospitalized and had undergone blood glucose measurements during hospitalization. Glycemic control was assessed using hemoglobin A1c, and the blood glucose levels were measured four times daily during hospitalization. Variability was quantified using the coefficient of variation and compared between hospitalist-led and traditional specialty care groups, over a 14-day hospitalization period. <b>Results:</b> Despite a higher baseline risk profile, patients receiving hospitalist-led care experienced significantly more stable glycemic variability over time (<i>p</i> = 0.002), suggesting better inpatient glucose management than those receiving traditional specialty care. <b>Conclusions:</b> Hospitalist-led care was associated with more stable glycemic variability over time in hospitalized patients with diabetes, despite a higher baseline burden of comorbidities and poorer glycemic control at admission.